Literature DB >> 8522190

Cloning of the rat ErbB3 cDNA and characterization of the recombinant protein.

N J Hellyer1, H H Kim, C H Greaves, S L Sierke, J G Koland.   

Abstract

Three cDNA fragments that encoded all but the extreme N terminus of the rat ErbB3 protein were cloned by low-stringency screening of a rat liver cDNA library with a human ERBB3 probe. The remaining 5'-end of the cDNA was generated by a reverse transcription-polymerase chain reaction method, and a single full-length rat ErbB3 cDNA was assembled. A comparison of the deduced amino acid (aa) sequences of human and rat ErbB3 was made, and the effects of certain aa substitutions in the putative protein tyrosine kinase domain were considered. The rat ErbB3 cDNA was subsequently expressed in cultured NIH-3T3 mouse fibroblasts, in which a high level of approx. 180-kDa recombinant ErbB3 (re-ErbB3) was generated. The rat re-ErbB3 produced in transfected fibroblasts was responsive to the polypeptide, heregulin, a known ligand for ErbB3. Challenge of transfected fibroblasts with heregulin stimulated the phosphorylation of rat re-ErbB3 on Tyr residues and promoted its association with the p85 subunit of phosphatidylinositol 3-kinase. Together, these results indicate that a fully functional rat ErbB3 cDNA has been isolated, and that fibroblast cells expressing this cDNA will be suitable for investigations of the signal transduction mechanism of ErbB3.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8522190     DOI: 10.1016/0378-1119(95)00436-a

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  ErbB3 (HER3) interaction with the p85 regulatory subunit of phosphoinositide 3-kinase.

Authors:  N J Hellyer; K Cheng; J G Koland
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

2.  Biochemical characterization of the protein tyrosine kinase homology domain of the ErbB3 (HER3) receptor protein.

Authors:  S L Sierke; K Cheng; H H Kim; J G Koland
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

3.  Presence of EGF growth factor ligands and their effects on cultured rat conjunctival goblet cell proliferation.

Authors:  Jian Gu; Lili Chen; Marie A Shatos; J David Rios; Abha Gulati; Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2007-11-17       Impact factor: 3.467

4.  Signal transduction by epidermal growth factor and heregulin via the kinase-deficient ErbB3 protein.

Authors:  H H Kim; U Vijapurkar; N J Hellyer; D Bravo; J G Koland
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

5.  Insights into the evolution of the ErbB receptor family and their ligands from sequence analysis.

Authors:  Richard A Stein; James V Staros
Journal:  BMC Evol Biol       Date:  2006-10-06       Impact factor: 3.260

6.  The docking protein Gab1 is the primary mediator of EGF-stimulated activation of the PI-3K/Akt cell survival pathway.

Authors:  Dawn R Mattoon; Betty Lamothe; Irit Lax; Joseph Schlessinger
Journal:  BMC Biol       Date:  2004-11-18       Impact factor: 7.431

7.  Interaction of the PA2G4 (EBP1) protein with ErbB-3 and regulation of this binding by heregulin.

Authors:  J Y Yoo; X W Wang; A K Rishi; T Lessor; X M Xia; T A Gustafson; A W Hamburger
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

8.  HER2 and HER3 cooperatively regulate cancer cell growth and determine sensitivity to the novel investigational EGFR/HER2 kinase inhibitor TAK-285.

Authors:  Shinji Takagi; Hiroshi Banno; Akira Hayashi; Toshiya Tamura; Tomoyasu Ishikawa; Yoshikazu Ohta
Journal:  Oncoscience       Date:  2014-03-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.